{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:35:13Z","timestamp":1793136913972,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872877"],"award-info":[{"award-number":["81872877"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91853109"],"award-info":[{"award-number":["91853109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.intimp.2021.107375","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T02:09:05Z","timestamp":1611886145000},"page":"107375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Curcumin analogue AI-44 alleviates MSU-induced gouty arthritis in mice via inhibiting cathepsin B-mediated NLRP3 inflammasome activation"],"prefix":"10.1016","volume":"93","author":[{"given":"Yanpin","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1425-0089","authenticated-orcid":false,"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2021.107375_b0005","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.molmed.2017.06.005","article-title":"Molecular Pathophysiology of Gout","volume":"23","author":"Desai","year":"2017","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2021.107375_b0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Gout. Nat. Rev. Dis. Primers."},{"issue":"11","key":"10.1016\/j.intimp.2021.107375_b0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.intimp.2021.107375_b0020","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clin. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2021.107375_b0025","first-page":"687","article-title":"BET 1: Prednisolone for the treatment of acute gouty arthritis","volume":"34","author":"Simon","year":"2017","journal-title":"Emerg. Med. J."},{"issue":"1","key":"10.1016\/j.intimp.2021.107375_b0030","first-page":"63","article-title":"Jia-Wei-Si-Miao-Wan alleviates acute gouty arthritis by targeting NLRP3 inflammasome","volume":"33","author":"Yuan","year":"2019","journal-title":"J. Biol. Regul. Homeost Agents."},{"key":"10.1016\/j.intimp.2021.107375_b0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.intimp.2016.12.031","article-title":"an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the upregulation of Nrf2 transcription factor and alleviates MSU crystal induced inflammation in rats","volume":"44","author":"Dinesh","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2021.107375_b0040","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.41245","article-title":"Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis","volume":"72","author":"Yang","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2021.107375_b0045","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3389\/fimmu.2018.01427","article-title":"Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages","volume":"9","author":"Amaral","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107375_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2020.07.003","article-title":"Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability","author":"Nidorf","year":"2020","journal-title":"J. Clin. Lipidol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107375_b0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nm.2999","article-title":"Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth","volume":"19","author":"Bruchard","year":"2013","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.intimp.2021.107375_b0060","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1080\/15548627.2017.1293766","article-title":"The role of NLRP3-CASP1 in inflammasome-mediated neuroinflammation and autophagy dysfunction in manganese-induced, hippocampal-dependent impairment of learning and memory ability","volume":"13","author":"Wang","year":"2017","journal-title":"Autophagy."},{"issue":"4","key":"10.1016\/j.intimp.2021.107375_b0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s13105-018-0644-y","article-title":"Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation","volume":"74","author":"Tang","year":"2018","journal-title":"J. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2021.107375_b0070","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1002\/jcb.27969","article-title":"Curcumin ameliorates monosodium urate-induced gouty arthritis through Nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa B signaling","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2021.107375_b0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13075-019-1974-z","article-title":"Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of I\u03baB\u03b1 and blocking mitochondrial damage","volume":"27;21","author":"Chen","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.intimp.2021.107375_b0080","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.1701495","article-title":"Curcumin Suppresses IL-1\u03b2 Secretion and Prevents Inflammation through Inhibition of the NLRP3 Inflammasome","volume":"15;200","author":"Yin","year":"2018","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2021.107375_b0085","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.4049\/jimmunol.1700796","article-title":"Targeting Peroxiredoxin 1 by a Curcumin Analogue, AI-44, Inhibits NLRP3 Inflammasome Activation and Attenuates Lipopolysaccharide-Induced Sepsis in Mice","volume":"201","author":"Liu","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107375_b0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2019.02.035","article-title":"Cathepsin B: A sellsword of cancer progression","volume":"449","author":"Mijanovic","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2021.107375_b0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.lfs.2018.01.020","article-title":"Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice","volume":"196","author":"Gonzalez","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2021.107375_b0100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fneur.2015.00178","article-title":"Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate","volume":"6","author":"Hook","year":"2015","journal-title":"Front. Neurol."},{"issue":"49","key":"10.1016\/j.intimp.2021.107375_b0105","doi-asserted-by":"crossref","first-page":"80262","DOI":"10.18632\/oncotarget.12918","article-title":"Andrographolide ameliorates OVA-induced lung injury in mice by suppressing ROS-mediated NF-kappaB signaling and NLRP3 inflammasome activation","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget."},{"issue":"2","key":"10.1016\/j.intimp.2021.107375_b0110","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3892\/or.2013.2496","article-title":"Silencing of Cathepsin B suppresses the proliferation and invasion of endometrial cancer","volume":"30","author":"Bao","year":"2013","journal-title":"Oncol. Rep."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2021.107375_b0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/prca.201300105","article-title":"Cathepsin B: multiple roles in cancer","volume":"8","author":"Aggarwal","year":"2014","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.intimp.2021.107375_b0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12943-016-0503-9","article-title":"Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients","volume":"15","author":"Ruan","year":"2016","journal-title":"Mol. Cancer."},{"issue":"8","key":"10.1016\/j.intimp.2021.107375_b0125","first-page":"518","article-title":"Neuronal death in amyotrofic lateral sclerosis","volume":"23","author":"Matias-Guiu","year":"2008","journal-title":"Neurologia."},{"issue":"3","key":"10.1016\/j.intimp.2021.107375_b0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0029-1242756","article-title":"Glioblastoma invasion, cathepsin B, and the potential for both to be inhibited by auranofin, an old anti-rheumatoid arthritis drug","volume":"71","author":"Kast","year":"2010","journal-title":"Cent Eur. Neurosurg."},{"issue":"7","key":"10.1016\/j.intimp.2021.107375_b0135","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1053\/j.gastro.2019.01.268","article-title":"Early Intra-Acinar Events in Pathogenesis of Pancreatitis","volume":"156","author":"Saluja","year":"2019","journal-title":"Gastroenterology."},{"key":"10.1016\/j.intimp.2021.107375_b0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.intimp.2019.05.006","article-title":"NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy","volume":"73","author":"Parsamanesh","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.107375_b0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction","volume":"8","author":"Chevriaux","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2021.107375_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105886","article-title":"Suppression of NLRP3 and NF-kappaB signaling pathways by alpha-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice","volume":"76","author":"Liu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107375_b0155","first-page":"2180","article-title":"NLRP3 inflammasome inactivation driven by miR2233p reduces tumor growth and increases anticancer immunity in breast cancer","volume":"19","author":"Zhang","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2021.107375_b0160","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4161\/auto.28374","article-title":"Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer","volume":"10","author":"Guo","year":"2014","journal-title":"Autophagy."},{"issue":"1","key":"10.1016\/j.intimp.2021.107375_b0165","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/s41467-017-02351-0","article-title":"Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2021.107375_b0170","unstructured":"G. Deng, W. Chen, P. Wang, et al., Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice, Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:27:39Z","timestamp":1761586059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":34,"alternative-id":["S1567576921000114"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107375","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin analogue AI-44 alleviates MSU-induced gouty arthritis in mice via inhibiting cathepsin B-mediated NLRP3 inflammasome activation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107375"}}